Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth.
Kazuyoshi Shiga,Masayasu Hara,Takaya Nagasaki,Takafumi Sato,Hiroki Takahashi,Hiromitsu Takeyama +5 more
TLDR
It is shown that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions, and CAFs contribute to drug-resistance acquisition in cancer cells.Abstract:
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.read more
Citations
More filters
Journal ArticleDOI
Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer.
TL;DR: In this article , different molecular subtypes of breast cancer showed heterogeneity in their tumor microenvironment (TME) also, which may provide new prognostic biomarkers and new targets for cancer therapy.
Patent
Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impact
TL;DR: In this paper, the authors used a patient's sequence data and distributions of biomarker values across one or more reference populations to calculate normalized scores for a first set of biomarkers associated with a first therapy and a second set of normalized scores associated with the second therapy.
Journal ArticleDOI
What is the Potential Interplay between Microbiome and Tumor Microenvironment in Oral Squamous Cell Carcinomas?
TL;DR: In this article , the authors summarized the current knowledge of the role of oral microbiome, focusing on its potential crosstalk with TME in oral squamous cell carcinomas (OSCC) more precisely, and pave the way for manipulating oral microbiome to deal with OSCC in the future.
Journal ArticleDOI
Commentary on Some Recent Theses Relevant to Combating Aging: February 2017.
OtherDOI
EV (Extracellular Vesicle)‐associated miRNAs as Biomarkers of Toxicity
TL;DR: In this article , the authors introduce the latest findings on exosomes, including newly appreciated biological significance of exosome-mediated horizontal gene transfer, and explain the potential use of Exosomes as biomarkers of toxicity.
References
More filters
Journal ArticleDOI
The biology of vascular endothelial growth factor
TL;DR: The establishment of a vascular supply is required for organ development and differentiation as well as for tissue repair and reproductive functions in the adult.
Journal ArticleDOI
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
TL;DR: Tumors of epithelioma are composed of two discrete but interdependent compartments: the malignant cells themselves and the stroma that they induce and in which they are dispersed.